New P2 trial • Combination therapy • Metastases
|
HER-2 (Human epidermal growth factor receptor 2) • MSI (Microsatellite instability)
|
MSI-H/dMMR • HER-2 negative
|
5-fluorouracil • Fruzaqla (fruquintinib) • leucovorin calcium • Kaitanni (cadonilimab)